BSE filing, NSE: JUBLPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Jubilant Pharmova Ltd: key numbers
- Share price
- ₹923.80
- Market cap
- ₹14,714 Cr
- Revenue (annual)
- ₹8,280 Cr
- Net profit (annual)
- ₹398.5 Cr
- P/E (TTM)
- 41.8×Sector 48.7×
- Promoter holding
- 47.68%+0.00% QoQ
- FII holding
- 15.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Pharmova Ltd
All →Jubilant Pharmova Annual General Meeting
Jubilant Pharmova Ltd has issued a Postal Ballot Notice seeking shareholder approval for the private placement issuance of Non-Convertible Debentures.
Jubilant Pharmova Credit Rating
Jubilant Pharmova received a credit rating of IND AA+/Stable from India Ratings and Research for its proposed Non-Convertible Debentures worth ₹1,400 Crore.
- Value
- ₹1,400 Cr
Jubilant Pharmova Other Announcement
Jubilant Pharmova Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Jubilant Pharmova Credit Rating
Jubilant Pharmova received an [ICRA]AA+ (Stable) rating from ICRA for its proposed non-convertible debentures. This confirms the credit assessment for the upcoming debt instrument.
Jubilant Pharmova Debt & Borrowing: ₹800 Cr
Jubilant Pharmova board approved NCD issuance up to ₹800 crore on private placement basis. Postal ballot also sought for NCD authorization up to ₹2,500 crore.
- Value
- ₹800.0 Cr
- Execution
- Upto five years from the Deemed Date of Allotment
Jubilant Pharmova Capacity Expansion: ₹633.1 Cr Investment
Jubilant Pharmova's Radiopharma business will invest CAD 94.5 million (approx. ₹633 Crore) to expand production capacity at its Kirkland facility, aiming to double RUBY-FILL® production.
- Value
- ₹633.1 Cr
- production capacity
- 2.0 times
Other board meeting date announcements
All →Workmates Core2Cloud Solution Board Meeting Date
Workmates Core2Cloud will hold a board meeting on November 4, 2026 to consider unaudited standalone and consolidated half-year results for September 2026. It will also review a monitoring agency report.
EID Parry (India) Board Meeting Date
E.I.D. - Parry (India) intimated a board meeting on November 13, 2026 to consider unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026. No amount or outcome is stated yet.
Yogi Infra Projects Board Meeting Date
Yogi Infra Projects has called a board meeting on 05 Nov 2026 to approve unaudited quarterly and half-year results. Trading window is closed for designated persons until results are declared.
One Global Service Provider Board Meeting Date
One Global Service Provider has intimated a board meeting on 4 November 2026 to consider unaudited standalone results for the quarter and half year ended September 2026. This is a prior intimation; the agenda is proposed only.
Sanrhea Technical Textiles Board Meeting Date
Sanrhea Technical Textiles has scheduled a board meeting for 6 November 2026 to consider unaudited quarterly and half-year results. This is an advance intimation; the agenda is proposed only.
Shradha AI Technologies Board Meeting Date
Shradha AI Technologies schedules a board meeting on 4 November 2026 to consider unaudited Q2 results. The trading window remains closed until results are announced.